Please assess the completion status of the following clinical trial:

Trial Title: Cacicol20® in Corneal Wound Healing and Nerve Regeneration After Phototherapeutic Keratectomy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Signed and dated informed consent,~* Male or female aged ≥ 18 years,~* Patient with recurrent erosions or epithelial dystrophies indicated for treatment by phototherapeutic keratectomy of the anterior cornea~Exclusion Criteria:~* In the affected eye: prior corneal surgery~* In either eye: active ocular infection, glaucoma, or ocular hypertension~* General history judged by the investigator to be incompatible with the study (life-threatening patient condition).~* Known allergic hypersensitivity history to Poly(carboxyMethylGlucoseSulfate) or dextran.~* Inability of patient to understand the study procedures and thus inability to give informed consent.~* Participation in another clinical study within the last 3 months.~* Already included once in this study (can only be included for one treated eye)~Specific exclusion criteria for women~* Known pregnancy (if uncertain pregnancy test will be performed)~* Lactation~* Women of childbearing potential without an effective method of contraception (oral contraceptive, intra-uterine device, subcutaneous contraceptive implant, vaginal ring) or women not hysterectomised, post-menopausal or surgically sterilized

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Cacicol20 (Type: EXPERIMENTAL): Instillation of Cacicol20 eye drops after laser corneal surgery. 3 eye drops total, to be given once immediately after surgery, once 2 days after surgery, and a final time 4 days after surgery.
- Placebo (Type: PLACEBO_COMPARATOR): Instillation of placebo eye drops (vehicle missing the active ingredient) after laser corneal surgery. 3 eye drops total, to be given once immediately after surgery, once 2 days after surgery, and a final time 4 days after surgery.

Based on this trial design, predict the completion outcome and termination type (if applicable).